Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 18.20% ano a ano.
Subavaliada
O PE mais recente da empresa é -70.88, em uma faixa percentil baixa de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 177.30M ações, uma redução de 20.60% em relação ao trimestre anterior.
Mantido por HACAX
O Super Investidor HACAX possui 241.12K ações desta empresa.
Alta Atividade de Mercado
A empresa tem maior interesse dos investidores, com uma taxa de giro de 20 dias de 1.27.